Vasylyev A, et al. - Researchers sought to describe health service utilization and to estimate the direct medical costs (DMCs) of chronic lymphocytic leukemia (CLL) in 2013 in the adult population of three post-Soviet countries – Russia, Ukraine, and Kazakhstan. Across the selected countries, CLL treatment standards varied. They noticed the higher usage of biologic therapy in Russia.